rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Natco Pharma Ltd.

524816 NATCOPHARM Group (A)

26 Jul,15:52
1332.45
8.40 (0.63%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Natco Pharma Ltd.

BUYSELL
64,854 1,324.05 1,349.00 - 1,311.10 1,311.00 - 714.65 23,864.18
NSE | BSE

Natco Pharma Ltd.

NATCOPHARM

26 Jul,15:56
1334.65
10.85 (0.82%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Natco Pharma Ltd.

BUYSELL
632,359 1323.80 1,349.00 - 1,312.00 1,339.80 - 724.20 842,820,722.38

News for Natco Pharma Ltd.

Standard Glass...
Standard Glass Lining IPO: ₹500 Crore Raise, Pharma Focus
Standard Glass Lining Technology, a leading manufacturer of pharma and chemical equipment, files for an IPO seeking ₹500 crore. The IPO includes fresh issuance and an OFS, with proceeds for debt...
Jul 26, 2024 13:08
Akums Drugs IPO...
Akums Drugs IPO Opens July 30: Rs 1,857 Cr Issue
Akums Drugs and Pharmaceuticals' IPO to raise Rs 1,857 crore opens on July 30. The price band is set at Rs 646-679 per share. Learn more about the IPO details.
Jul 25, 2024 10:48
USFDA Warns Natco...
USFDA Warns Natco Pharma for Manufacturing Lapses
USFDA issued a warning letter to Natco Pharma for violations at its Telangana plant, citing cleanliness, sterilization, and contamination concerns. The regulator has asked for a comprehensive...
Apr 21, 2024 10:45
Natco Pharma...
Natco Pharma Faces US Lawsuit Over Diazepam Injection
Fresenius Kabi has filed a complaint against Natco Pharma in a US district court over the marketing of Diazepam injection prefilled syringes. Natco Pharma plans to defend the lawsuit.
Apr 18, 2024 10:55
Natco Pharma Gets...
Natco Pharma Gets USFDA Warning Letter for Telangana Plant
Natco Pharma received a warning letter from the USFDA for its Telangana plant due to violations found during an inspection. The company assures minimal impact on supplies and revenues but...
Apr 09, 2024 10:51

More News for Natco Pharma Ltd. »

(Rs. Crore)

Financial Results of Natco Pharma Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales3,568.902,351.001,767.801,653.501,790.20
Operating profit1,637.00844.70213.00417.60578.00
Interest14.508.6013.3011.3020.60
Gross profit1,727.20921.60294.30507.40681.20
EPS (Rs)72.9934.917.6216.9626.07

See more in Research Center »

Statements:Balance Sheet  |  P&L  |  Cash Flow
More:Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

About Natco Pharma Ltd.

Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations active pharmaceutical ingredients and Agro chemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs. The company specialises in producing complex medicines at affordable prices. NATCO is a science driven company and focuses on limited competition molecules in the US. Wikipedia

News for Pharmaceuticals and health care

Aditya Birla...
Aditya Birla Group Targets USD 25 Billion Consumer Business Revenue
Aditya Birla Group aims to reach USD 25 billion in consumer business revenue in the next 5 years, driven by diversification and portfolio strengthening. The group is focused on financial services,...
Jul 26, 2024 22:32
Sebi Confirms...
Sebi Confirms Order Against 12 in V Marc India Fraud
Sebi confirms its order against 12 entities, including V Marc India's promoter, for a fraudulent scheme to manipulate stock prices.
Jul 26, 2024 22:25
PM GatiShakti...
PM GatiShakti Evaluates 5 Infra Projects: Road, Rail
Network Planning Group (NPG) has evaluated 5 infrastructure projects, including road and rail, under the PM GatiShakti initiative, focusing on integrated planning.
Jul 26, 2024 22:10
Fortune Wealth...
Fortune Wealth Targets Rs 500 cr Multi-Cap Fund
Fortune Wealth aims to raise Rs 500 crore for its multi-cap portfolio fund within 5 months. The fund, launched in June 2024, has already gathered Rs 320 crore.
Jul 26, 2024 22:05
Kargil Vijay...
Kargil Vijay Diwas: India Post Releases Commemorative Stamp
India Post commemorates the 25th anniversary of Kargil Vijay Diwas with a special postage stamp, honoring the bravery of Indian armed forces.
Jul 26, 2024 22:04

More News »

Top News

G20 Agrees to Tax...
G20 Agrees to Tax Super-Rich, Brazil Leads Effort
Finance ministers from G20 nations agree to work toward taxing the super-rich, a significant step toward addressing global inequality. Brazil's proposal for a 2% minimum tax on billionaires is...
Jul 27, 2024 03:35
Aditya Birla...
Aditya Birla Group Targets USD 25 Billion Consumer Business Revenue
Aditya Birla Group aims to reach USD 25 billion in consumer business revenue in the next 5 years, driven by diversification and portfolio strengthening. The group is focused on financial services,...
Jul 26, 2024 22:32
Sebi Confirms...
Sebi Confirms Order Against 12 in V Marc India Fraud
Sebi confirms its order against 12 entities, including V Marc India's promoter, for a fraudulent scheme to manipulate stock prices.
Jul 26, 2024 22:25
PM GatiShakti...
PM GatiShakti Evaluates 5 Infra Projects: Road, Rail
Network Planning Group (NPG) has evaluated 5 infrastructure projects, including road and rail, under the PM GatiShakti initiative, focusing on integrated planning.
Jul 26, 2024 22:10
Fortune Wealth...
Fortune Wealth Targets Rs 500 cr Multi-Cap Fund
Fortune Wealth aims to raise Rs 500 crore for its multi-cap portfolio fund within 5 months. The fund, launched in June 2024, has already gathered Rs 320 crore.
Jul 26, 2024 22:05

More Top News »

Report Card

PE Ratios
18.25
EPS (Rs.)
72.99
Sales (Rs. Cr)
964.80
Face Value (Rs.)
2
Net Profit Margin (%)
27.09
Last Bonus
Last Dividend(%)
62.5
Return on Average Equity
13.54

BSE Announcements from Natco Pharma Ltd. (See all)

announcement Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter Ended June 30, 2024 And Declaration Of Interim Dividend For FY 2024-25, If Any - 1 day(s) ago
announcement Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate - 2 day(s) ago

Compare 'Natco Pharma Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,665.20
  • Compare
  • Divi's Laboratories Ltd.
  • 4,549.75
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,205.60
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,854.20
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,087.85
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,388.60
  • Compare
  • Max Healthcare Institute Ltd.
  • 926.50
  • Compare
  • Alkem Laboratories Ltd.
  • 5,178.80
  • Compare

Mutual Funds Invested

Most Active

  • Change (Rs.)
  •  

REDIFFGURUS

I am 25. I am investing 12.5k in HDFC Nifty 50 index...

Is it advisable to redeem from Mutual funds less...

Hello Sir I am an NRI and I still have an old SB...

My husband is 50 and I am 47. We have a combined...

Sir My age is 53. My PF contribution from salary is...

Hello, Shri Vivekji, my wife purchased plots worth...

More REDIFFGURUS

RediffGurus

Money question

Sir, I had initially started SIP in mutual funds via...

Natco Pharma Ltd. performance snapshot

If you had invested Rs.  in Natco Pharma Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
Natco Pharma Ltd.
Share Price » Fundamentals » Financial » Technicals » Trade Now »

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume

ALL MONEYWIZ PAGES

rediff on the net© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
Close
Add Natco Pharma Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Natco Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close